GYNAECOLOGICAL CANCERS

Clinical trials for GYNAECOLOGICAL CANCERS explained in plain language.

Never miss a new study

Get alerted when new GYNAECOLOGICAL CANCERS trials appear

Sign up with your email to follow new studies for GYNAECOLOGICAL CANCERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 1

Gene-Guided drug cocktail shows promise for Tough-to-Treat gynaecological cancers

Disease control Ongoing

This phase 2 trial tests a new drug (ceralasertib) alone or combined with either olaparib or durvalumab in 174 people whose gynaecological cancer has returned. The study groups patients by their cancer type and whether they have a change in the ARID1A gene. The goal is to see if …

Matched conditions: GYNAECOLOGICAL CANCERS

Phase: PHASE2 • Sponsor: Institute of Cancer Research, United Kingdom • Aim: Disease control

Last updated Jun 27, 2026 09:07 UTC

GYNAECOLOGICAL CANCERS

Get alerted when new GYNAECOLOGICAL CANCERS trials appear

Gene-Guided drug cocktail shows promise for Tough-to-Treat gynaecological cancers